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Helicobacter pylori is the etiological agent of diseases such as gastritis, gastric and duodenal ulcers, and two
types of gastric cancers. While some insight has been gained into the etiology of these diverse manifestations,
by and large, the reason that some individuals develop more severe disease remains elusive. Recent studies
have focused on the roles of H. pylori toxins CagA and VacA on the disease process and have suggested that
both toxins are intimately involved. Moreover, CagA and VacA are polymorphic within different H. pylori
strains, and particular polymorphisms seem to show a correlation with the development of particular disease
states. Among VacA polymorphisms, the intermediate region has recently been proposed to play a major role
in disease outcome. In this article, we describe a detailed sequence analysis of the polymorphic intermediate
region of vacA from strains obtained from a large South Korean population. We show that polymorphisms
found at amino acid position 196 are associated with more severe disease manifestations. Additionally,
polymorphisms found at amino acid position 231 are linked to disease in strains that carry the non-EPIYA-
ABD allele of CagA. Collectively, these data help explain the impact of the VacA intermediate region on disease
and lead to the hypothesis that there are allele-driven interactions between VacA and CagA.
The medically important microbe Helicobacter pylori colo-
nizes the inhospitable niche of the gastric mucosa of over 50%
of the world’s population (34, 54). H. pylori is a spiral-shaped,
microaerophilic, Gram-negative bacterium (33) that is the eti-
ological agent of a multitude of diseases, including gastritis,
peptic ulcers (both duodenal and gastric ulcers), as well as
adenocarcinoma and mucosa-associated lymphoid tissue
(MALT) lymphoma (6, 12, 17, 18, 45). This class I carcinogen
contributes to gastric cancer mortality, which is still one of the
most common causes of mortality due to cancer (18, 42). This
is especially true in East Asian countries, such as China, South
Korea, and Japan (23).
Two H. pylori toxins that facilitate host cellular damage and
directly interplay with the host immune system are the cyto-
toxin-associated gene A (CagA) and the vacuolating cytotoxin
(VacA). A growing number of studies have begun to suggest
that VacA and CagA interact in such a way as to affect disease
severity (2, 27, 59, 62). VacA was identified within a few years
of the discovery of H. pylori and appears to be produced and
secreted by virtually all strains (4, 13). This toxin was initially
identified and named for its ability to cause large cytoplasmic
vacuoles in intoxicated host cells (14). However, VacA has
subsequently been shown to have a multitude of functions. For
instance, when inserted into the plasma membrane, VacA can
act as an anion-selective channel (52), which may aid bacterial
survival through leakage of host cytosolic anions that can be
utilized by the bacterium (40). VacA also has the ability to
induce apoptosis through permeabilization of the mitochon-
drial membrane, thereby causing cytochrome c release (32, 60).
Furthermore, VacA can induce the autophagy pathway (53),
disorganize the host cell cytoskeleton to cause spreading of
host cells, inhibit T cell activation, and block T cell and B cell
proliferation (20, 56).
CagA is directly injected into host cells through a type IV
secretion apparatus (10) and is phosphorylated within host
cells by host cell kinases. This phosphorylation event subse-
quently makes CagA competent for interaction with the Src
homology 2 domain-containing protein tyrosine phosphatase
(SHP-2) (23, 26). The downstream effects of this interaction
include alterations in numerous host signaling pathways (22,
24–26, 41, 48, 58), which are believed to be responsible for the
increased cancer risk associated with infection by strains that
express CagA (7, 21). Phosphorylation of CagA occurs in the
carboxy terminus of the protein at conserved tyrosine residues
that exist as part of a repeated 5-amino-acid sequence (Glu-
Pro-Ile-Tyr-Ala) referred to as the EPIYA repeat (25, 26). The
numbers of these EPIYA repeats and the flanking amino acid
regions surrounding these repeats vary dramatically across
strains. On the basis of flanking sequences, four distinct
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EPIYA motifs have been identified (EPIYA-A, -B, -C, and -D)
(25, 61). Strains that carry various combinations of these motifs
can be divided into two main geographical distributions, which
are hallmarked by differences in the primary phosphorylation
sites, EPIYA-C and -D (25); East Asian strains contain
EPIYA-ABD, whereas Western strains contain EPIYA-ABC
and the EPIYA-C motif may be repeated up to five times (2,
25, 26, 43). These different EPIYA combinations have been
suggested to impact disease progression (29, 61).
Similar to the polymorphic nature of CagA, VacA contains
three distinct segments that exhibit variation starting within the
amino terminus. These areas of variation are broadly defined
as the signal (s), intermediate (i), and middle (m) regions, and
two or more primary variants have been described for each
region: s1 and s2 for the signal region, i1, i2, and i3 for the
intermediate region, and m1 and m2 for the middle region (3,
11, 47). Various combinations of each s, i, and m region are
then combined within each H. pylori strain to yield a particular
vacA allele. The s region of VacA appears to influence the
efficiency of anion channel formation based on the hydropho-
bicity of amino acid residues that are found near a proteolytic
cleavage site found in this region (35, 46); the s1 form contains
a hydrophobic region adjacent to the proteolytic cleavage site
that increases membrane insertion and formation of mem-
brane channels (30, 35). The m region affects host cell tropism
(28); VacA toxins with the m1 region are toxic to a broader
range of host cells (1, 44). The i region is positioned between
the s and m regions and is the most recent region to be de-
scribed. The i1 variants of VacA have been shown to have
stronger vacuolating activity than toxins containing the i2 re-
gions (47). Due to the increased anion channel formation ca-
pability, broader cell tropism, and enhanced vacuolating activ-
ity, individual associations between the s1, m1, and i1 types and
more-severe forms of H. pylori-induced disease have been
identified (5, 47). Furthermore, several studies have linked
strains carrying the s1-m1 allele of the toxin to more-severe
disease outcomes, since these strains show the strongest vacu-
olating activity to the broadest range of cells (31). However,
recently, the i region has been suggested to be a better predic-
tor of disease severity than either the s or m region, though the
i region appears to covary with the s and m regions (47). This
means that the more toxic i1 region is often associated with
s1-m1 (47).
Within the i region, three specific clusters have been iden-
tified as the main areas to contain polymorphisms, clusters A,
B, and C. Of these three clusters, clusters B and C have been
shown to impact the vacuolating activity of the toxin (47).
Because of this link to toxin activity, researchers have sought to
determine the roles of natural individual amino acid changes
within these clusters in the ultimate outcome of disease. For
example, variation in the ninth amino acid in cluster B (amino
acid 231 of the protoxin) has been linked to disease develop-
ment in the Taiwanese population (50). However, this amino
acid appeared to have no impact in the South Korean popu-
lation (27). Recently, we identified two additional positions in
the VacA intermediate region that contained polymorphisms,
positions 151 and 196 (27). While neither of these amino acids
showed a statistically significant link to disease severity in the
small population of samples that were examined, the distribu-
tion of amino acids found at position 196 displayed a trend
toward significance (27). Given this, we sequenced the vacA
intermediate region from 231 Korean isolates and then ana-
lyzed the distribution of polymorphisms across the entire re-
gion. Furthermore, we compared these polymorphic vacA dis-
tributions to the various cagA alleles carried by each strain as
well as to the ultimate disease development. In this article, we
present an expanded i1 and i2 consensus sequence, show that
amino acid 196 impacts disease development, and show that
amino acid 231 is important for disease development, but only
within strains that carry a non-EPIYA-ABD CagA allele.
MATERIALS AND METHODS
Bacterial strains and culture conditions. This South Korean population of 260
strains has been described previously and includes 115 isolates from patients
diagnosed with gastritis, 60 isolates from patients diagnosed with gastric ulcer, 55
isolates from patients diagnosed with duodenal ulcer, and 30 isolates from
patients diagnosed with gastric cancer (27, 29). Isolates were preserved as stocks
at 80°C and then grown and expanded on antibiotic-supplemented horse blood
agar plates under microaerophilic conditions created by an Anoxomat evacua-
tion/replacement system (Spiral Biotech, Norwood, MA) exactly as previously
described (9, 29).
vacA i-region sequencing. Chromosomal DNA from each of the 260 H. pylori
strains was isolated using the Easy-DNA kit (Invitrogen, Carlsbad, CA). The
vacA intermediate region was amplified and then Sanger dideoxy sequenced
using the primers previously described by Rhead et al. (47), VacF1 (3-GTTG
GGATTGGGGGAATGCCG-5) and VacR9 (3-TGTTTATCGTGCTGTATG
AAGG-5). Sanger dideoxy sequencing was performed at both the Uniformed
Services University of the Health Science Biomedical Instrumentation Center
(Bethesda, MD) and Cosmo Genetech Co., Ltd. (Seoul, South Korea). The
resulting DNA sequences were analyzed using Vector NTI version 9.1 (Invitro-
gen, Carlsbad, CA) and Sequencher 4.5 (Gene Codes Corp., Ann Arbor, MI).
The amino acid numbering system used in this study is based on the VacA
sequence of strain G27; the numbering begins at the translational start such that
amino acid 1 is the first methionine of the translated protein.
Statistical analysis. The Fisher exact test was used to analyze the association
between the vacA allele, disease state, cagA allele, and specific amino acids
within the intermediate region. Log linear modeling was used to assess higher-
order associations that were significant at the 5% level. We fit a saturated model
using categorical variables representing vacA genotype, cagA genotype, disease
state, gender, and amino acids within the i region using a backward selection
algorithm, which eliminates the least significant association at each step and then
reforms the model to look for associations. Data were analyzed using SPSS
version 16 software (SPSS Inc., Chicago, IL) or SAS version 9.1 software (SAS
Institute Inc., Cary, NC).
Nucleotide sequence accession numbers. The sequences for the i region of
vacA from the 60 original strains analyzed (27) were previously deposited in
GenBank under accession numbers GQ338184 to GQ338243, and the i-region
sequences of the additional 171 strains have been deposited in GenBank under
accession numbers HM047564 to HM047592 and HM047594 to HM047735 (see
Table S1 in the supplemental material).
RESULTS
Sample acquisition and vacA i-region sequencing. The
strains used in this study have been previously characterized
for distribution of both the cagA allele (27, 29) and the vacA
allele (27). However, the previous study characterizing the
vacA allele relied primarily on PCR-based typing methods and
analyzed only the vacA intermediate region sequence from a
subset of strains carrying the i1 allele, whereas in the current
study, a detailed analysis of vacA sequences from the complete
collection of South Korean strains was performed. The com-
plete collection of 260 strains contained 254 strains for which
we had complete epidemiological data. These 254 strains were
obtained from patients with a mean age of 51 years and an age
range of 14 to 86 years. These strains were evenly distributed
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by gender; 126 strains were from female patients with a mean
age of 53 years and an age range of 21 to 86 years, and 128
strains were from male patients with a mean age of 50 years
and an age range of 14 to 82 years. These strains were distrib-
uted across various H. pylori-induced disease states: 45% were
from patients diagnosed with gastritis, 22% were patients di-
agnosed with gastric ulcers, 21% patients diagnosed with du-
odenal ulcers, and 12% patients diagnosed with gastric cancer
(29).
Of the 260 strains in this entire collection, the vacA i regions
in 231 strains were successfully sequenced, and we had com-
plete epidemiological data and CagA and VacA genotypes for
222 of these strains (Fig. 1 and Table 1; see Table S1 in the
supplemental material). These sequenced regions were from
strains from patients with an age range of 14 to 86 years and a
mean age of 50.3 years. Of the 222 isolates, 112 were from male
patients aged 14 to 82 years with a mean age of 48.9 years, and
110 were from female patients aged 21 to 85 years with a mean
age of 51.7 years. The sequenced strain distribution across
disease states was similar to that of the overall population;
45.5% were from patients with gastritis, 41% were from pa-
tients suffering from ulcers (22.1% duodenal ulcers and 18.9%
gastric ulcers), and 13.5% were from patients with cancer.
Vac i regions i1, i2, and i3. The fact that the vacA i region
shows polymorphism that may affect toxin activity was reported
only recently. At that time, consensus sequences were identi-
fied for the i1 and i2 regions based on sequences from strains
60190 and Tx30a, respectively (Fig. 2) (47). Subsequently, the
consensus sequences for the i1 and i2 regions were verified by
analysis of 123 strains from four distinct populations by Chung
et al., who also described an i3 region that appears to be a
hybrid of the i1 and i2 sequences (11).
On the basis of this new (i1, i2, and i3) nomenclature, our
South Korean population contained four different vacA alleles,
s1-i1-m1 (200 isolates), s1-i1-m2 (11 isolates), s1-i2-m2 (eight
isolates), and s1-i3-m1 (three isolates) (Table 1). All three of
the isolates defined as having an i3 region contained an i2
cluster B consensus sequence and an i1 cluster C consensus
sequence (Fig. 1 and 2). Of the s1-i1-m1 strains, 92 were from
gastritis patients, 41 were from duodenal ulcer patients, 40
were from gastric ulcer patients, and 27 were from gastric
cancer patients. Four of the s1-i1-m2 strains were from gastritis
patients, four were from duodenal ulcer patients, one was from
a gastric ulcer patient, and two were from cancer patients. Of
the eight s1-i2-m2 strains, four were from gastritis patients,
three were from duodenal ulcer patients, and one from a
gastric ulcer patient. The three s1-i3-m1 strains were from one
gastritis patient, one duodenal ulcer patient, and one cancer
patient (Table 1). There was no statistical association between
the distribution of the vacA alleles and the different disease
states (P  0.6865).
Given the fact that we were able to determine the i-region
sequence from 231 strains, we next examined the i-region se-
quences to identify amino acids that predominated in East
Asian strains, as well as to determine the amino acid differ-
ences between the i1 and i2 vacA alleles that might differ from
the defined consensus sequence (47). For this analysis, we
defined the consensus sequence in our South Korean popula-
tion as the amino acids encoded for by genes from at least 85%
of all strains. Comparison of our consensus sequence to that
defined by Rhead et al. (47) revealed the following. In cluster
A, we found the following. (i) There was a phenylalanine
instead of tyrosine at the first amino acid for the i1 allele. (ii)
The 12th and 14th amino acids of the i2 allele were reversed
(asparagine, phenylalanine, and aspartic acid versus aspartic
acid, phenylalanine, and asparagine in our population). (iii)
The main difference between the i1 and i2 vacA alleles in our
population were the fourth and sixth amino acids (i1: SAD and
i2: GAN) (Fig. 2). In cluster B, we found the following. (i) Our
population displayed variability at the ninth amino acid of the
i1 allele compared to the previously described serine. (ii) The
first two amino acids of the i2 alleles in our population were
similar to the first two amino acids of the i1 sequence and
contained glutamine followed by alanine rather than the lysine
followed by serine found in other populations. (iii) The major
differences in cluster B sequences in i1 and i2 alleles in our
population were the fifth, ninth, and tenth amino acids (Fig. 2)
(11, 47). In cluster C, we found the following. (i) There was a
methionine instead of an asparagine at the eighth amino acid
of the i1 allele in our population. (ii) There was a histidine
instead of a glutamine at the sixth amino acid of the i2 allele.
(iii) The major differences in cluster C sequences in the i1 and
FIG. 1. WebLogo image showing the VacA intermediate region’s major polymorphic domains within the South Korean population. The
WebLogo image was created by using the amino acid sequence from each of the three different intermediate alleles (220i1 sequences, 8 i2
sequences, and 3 i3 sequences) with the WebLogo generator as previously described (15, 49). The three primary regions of polymorphism (clusters
A, B, and C) and the two amino acids shown to impact disease development (at positions 196 and 231) are indicated. The logo represents the
alignment at each position by a stack of letters, where the height of each letter is proportional to the observed frequency of the corresponding
amino acid, and the overall height of each stack is proportional to the sequence conservation, measured in bits, at that position (15).
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TABLE 1. Distribution of cagA and vacA alleles in patients with different diseases
Allele and patient
gender Parameter
Value for parameter for patientsa
All Gastritis Duodenal ulcers Gastric ulcers Gastric cancer
Overall
All patients No. of patients 222 101 49 42 30
Age range (yr) 14–86 19–82 14–72 34–84 37–86
Mean age (yr) 50.3 48.3 45.1 55.1 56.6
Male No. of patients 112 34 30 32 16
Age range (yr) 14–82 19–76 14–70 34–82 38–70
Mean age (yr) 48.9 46.6 41.3 54.5 55.1
Female No. of patients 110 67 19 10 14
Age range (yr) 21–86 21–82 31–72 46–84 37–86
Mean age (yr) 51.7 49.2 51.1 57.1 61
cagA
EPIYA-ABD
All patients No. of patients 189 81 40 38 30
Age range (yr) 14–86 19–78 14–72 34–84 37–86
Mean age (yr) 50.5 48.9 44.5 54.5 57.9
Male No. of patients 100 25 29 30 16
Age range (yr) 14–82 19–78 14–70 34–82 38–70
Mean age (yr) 48.9 48.1 41.6 53.5 55.1
Female No. of patients 89 56 11 8 14
Age range (yr) 21–86 21–75 36–72 46–84 37–86
Mean age (yr) 52.2 49.2 52.1 58.4 61
Otherb
All patients No. of patients 33 20 9 4 0
Age range (yr) 28–82 28–82 31–61 48–81 N/A
Mean age (yr) 49.3 47.7 47.8 60.8 N/A
Male No. of patients 12 9 1 2 0
Age range (yr) 33–81 36–61 33 58–81 N/A
Mean age (yr) 48.8 46 N/A 69.5 N/A
Female No. of patients 21 11 8 2 0
Age range (yr) 28–82 28–82 31–61 48–56 N/A
Mean age (yr) 49.5 49 49.6 52 N/A
vacA
s1-i1-m1
All patients No. of patients 200 92 41 40 27
Age range (yr) 14–84 19–78 14–70 34–84 37–78
Mean age (yr) 49.8 48.5 43 54.9 57
Male No. of patients 104 32 27 32 15
Age range (yr) 14–82 19–78 14–70 34–82 38–70
Mean age (yr) 50.1 48.2 40.3 54.5 55.9
Female No. of patients 94 60 14 8 12
Age range (yr) 21–84 21–75 31–61 46–84 37–78
Mean age (yr) 50.5 48.7 48.3 56.5 58.3
s1-i1-m2
All patients No. of patients 11 4 4 1 2
Age range (yr) 38–82 38–82 41–57 63 44–68
Mean age (yr) 53.9 54 50.5 N/A 56
Male No. of patients 2 0 1 0 1
Age range (yr) 41–44 N/A 41 N/A 44
Mean age (yr) 42.5 N/A N/A N/A N/A
Female No. of patients 9 4 3 1 1
Age range (yr) 38–82 38–82 48–57 63 68
Mean age (yr) 56.4 54 53.7 N/A N/A
Continued on following page
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i2 alleles were the insertion of three additional amino acids in
the i2 allele, an asparagine, histidine, and serine, after the
fourth amino acid and then subsequent differences in the 1st,
3rd, 6th, 8th, and 10th amino acids of the i1 allele (correlating
with the 1st, 3rd, 9th, 11th, and 13th amino acids of the i2
allele, respectively) (Fig. 2) (11, 47).
The newest allele of the intermediate region, the i3 region
has been defined as the region that contains a cluster B se-
quence from either the i1 or i2 allele and a cluster C sequence
from the other allele (11). This South Korean population con-
tained three i3 strains. All of these strains contained a cluster
B sequence from an i2 allele and a cluster C sequence from an
i1 allele. The differences in the cluster A sequence in this
population between an i1 allele and an i2 allele are the fourth
TABLE 1—Continued
Allele and patient
gender Parameter
Value for parameter for patientsa
All Gastritis Duodenal ulcers Gastric ulcers Gastric cancer
s1-i2-m2
All patients No. of patients 8 4 3 1 0
Age range (yr) 38–72 38–68 61–72 56 N/A
Mean age (yr) 56.6 50.8 64.7 N/A N/A
Male No. of patients 2 1 1 0 0
Age range (yr) 43–61 43 61 N/A N/A
Mean age (yr) 52 N/A N/A N/A N/A
Female No. of patients 6 3 2 1 0
Age range (yr) 38–72 38–68 61–72 56 N/A
Mean age (yr) 58.2 53.3 66.5 N/A N/A
s1-i3-m1
All patients No. of patients 3 1 1 0 1
Age range (yr) 32–86 32 47 N/A 86
Mean age (yr) 55 N/A N/A N/A N/A
Male No. of patients 2 1 1 0 0
Age range (yr) 32–47 32 47 N/A N/A
Mean age (yr) 39.5 N/A N/A N/A N/A
Female No. of patients 1 0 0 0 1
Age range (yr) 86 N/A N/A N/A 86
Mean age (yr) N/A N/A N/A N/A N/A
a N/A, not applicable.
b Any genotype other than EPIYA-ABD, including Western strains and EPIYA-AABD, -BD, -BBD, -ABAB**D, and -AB**D where a mutation within the
EPIYA-B motif is designated by two asterisks.
FIG. 2. Consensus sequences for the vacA intermediate region. The consensus sequences of the i1 and i2 regions were previously defined by
Rhead et al. (47) and Chung et al. (11) and are shown in comparison to sequences obtained in this study. Differences in the various i1 and i2
consensus sequences or differences in the i3 sequences are indicated by dark gray shading. Amino acids that are different in the i1 and i2 strains
are indicated by light gray shading. A position where there is no consensus for the amino acid is indicated by a period. The points of insertion of
additional amino acids that are found only in cluster C of the i2 allele are indicated by dashes.
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and sixth amino acids. It is noteworthy that the three i3 se-
quences showed no consensus for these amino acids; one i3
sequence was identical to the i1 consensus sequence, another
was identical to the i2 consensus sequence, and one contained
two different amino acids (Fig. 2).
Amino acid 151. In-depth sequence analysis of the entire i
region revealed that, as previously described (27), amino acid
151 showed polymorphism. Strains contained either a tyrosine
(91 isolates [41%]) or phenylalanine (131 isolates [59%]) at
this position. The distribution of amino acids at this position
was not associated with gender (P  0.1749); the distribution
between males and females was fairly even (Table 2). In agree-
ment with the smaller subset of isolates we previously analyzed
(27), there was no association with variation at this residue and
the CagA allele (P 0.4433). Variation was also not associated
with the overall VacA allele (P  0.2177) or with either the i
(P  0.1692) or m (P  0.8097) subregions of the VacA allele.
Polymorphisms at this amino acid also did not impact disease
state, even when individual disease states were compared di-
rectly to each other (Table 3).
Amino acid 231. Amino acid 231, which is the ninth amino
acid in cluster B, was previously shown to contain amino acid
polymorphisms that are important for disease development in
a Taiwanese population (50). In our South Korean population,
we identified five different amino acids at this position: glycine,
serine, aspartic acid, asparagine, and arginine. To determine
whether the residue at this position was important, statistical
associations were analyzed across all the different amino acids
and for glycine versus all other amino acids combined; a pre-
vious study identified the presence of the glycine residue as
important for the progression to more severe disease (50).
Since we identified no difference between which associations
were statistically significant and since the previous literature
assessed the glycine residue versus any other amino acid (50),
the numbers we present compare glycine versus all other
amino acids found at position 231. The amino acid at position
231 was not associated with gender (P 0.1109) (Table 2). The
strong association we previously identified using a subset of
South Korean isolates (27) between the distribution of amino
acid polymorphisms at this position and the distribution of the
CagA allele was maintained in this larger population (P 
0.0081). More specifically, among EPIYA-ABD strains, glycine
was more prevalent at this position (72.5%) than among strains
carrying a non-EPIYA-ABD cagA allele (48.5%). Polymor-
phisms at this site were also associated with the overall VacA
allele (P  0.0001), every subregion of the VacA allele (i
region, P  0.0001; m region, P  0.0168), and every combi-
nation of subregions (s and i regions, P  0.0001; m and i
regions, P  0.0001; s and m regions, P  0.0168). However,
even though glycine at this position was previously identified as
important for the progression to more severe disease (50), we
found that polymorphisms at this position did not impact the
disease state. Additionally, there was no significance when
comparing across any individual disease, whether individual
disease states were compared alone or whether a combination
of disease states was analyzed (Table 3). These data suggest
that this amino acid is not important for disease progress or
that other factors are masking the contribution of this amino
acid to disease state in the South Korean population.
Amino acid 196. As we previously reported for a subset of
South Korean strains (27), amino acid 196 was identified as a
position that contained amino acid polymorphisms. In this
larger population, either a serine (148 isolates [67%]) or a
leucine (74 isolates [33%]) was found at this position. The
distribution of amino acids at this position was not associated
with gender (P  0.7762) and was fairly evenly distributed
between males and females (Table 2). Additionally, there was
still no association with the CagA allele (P  0.6928). How-
ever, polymorphisms at this residue were associated with the
VacA allele (P  0.0003). This association was present for the
i region of the VacA allele (P  0.0001) or any combination
that contained the i region (s and i regions, P  0.0001; m and
i regions, P 0.0003). However, there was no association when
the m region was assessed alone (P  0.7600) or when the
combination of regions did not include the i region (s and m
regions, P  0.0760). In fact, all of the i2 strains contain a
leucine at this position (Fig. 1).
Polymorphisms at this amino acid did not impact disease
state (P  0.0624) as a whole (Table 3). Additionally, this
position was not significant when gastritis was compared to any
noncancer disease state: gastritis versus all other disease states
(duodenal ulcers, gastric ulcers, and gastric cancers) (P 
0.3916), gastritis versus peptic ulcers (both duodenal and gas-
tric ulcers) (P  0.8808), gastritis versus duodenal ulcers (P 
0.4796), or gastritis versus gastric ulcers (P  0.2500). It was
also not significant when peptic ulcers were compared to non-
cancer disease states: duodenal ulcers versus all other disease
states (P  0.1237), duodenal ulcers versus gastric ulcers (P 
0.1250), or gastric ulcers versus all other disease states (P 
0.3636). There was also no association with the amino acid at
position 196 with gastric cancers versus peptic ulcers (P 
0.0689). However, we did find an association between the
amino acid at this position and the development of gastric
cancer to development of all other disease states (P  0.0389),
versus duodenal ulcers alone (P  0.0254), and versus gastritis
alone (P  0.0460). Additionally, there was a statistical asso-
ciation between polymorphisms at position 196 and more-se-
vere disease manifestations (gastric ulcers and gastric cancer)
versus less-severe disease manifestations (gastritis and duode-
nal ulcers) (P  0.0155) (Table 3). While the presence of a
serine at this position was more prevalent in all patients, pa-
tients suffering from gastric cancer were five times more likely
than other patients to carry a serine at this location. These data
suggest that position 196 does impact disease development but
that the overall impact is masked by the progression of this
disease through gastric ulcers.
Higher-order associations. Log linear modeling using a
combination of available data revealed two direct three-way
associations: disease state, cagA allele, and variation at amino
acid 231 (P  0.012) and disease state and variation at amino
acids 196 and 231 (P  0.029). As mentioned above, we found
no direct association with variation of amino acid 231 and
disease state in our population (P  0.8914). However, we
noted that the two direct three-way associations described
above involved disease state and amino acid 231, or disease
state, amino acid 231, and the cagA allele. We therefore asked
whether the presence of a Western or East Asian CagA allele
affected the ability of variation at residue 231 to be associated
with disease progression. We found that a two-way association
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TABLE 2. Distribution of amino acids at polymorphic positions within the intermediate region
Amino acid and
patient gender Parameter
Value for parameter for patientsa
All Gastritis Duodenal ulcers Gastric ulcers Gastric cancer
Amino acid 151
Tyrosine
All patients No. of patients 91 41 15 20 15
Age range (yr) 14–84 25–74 14–70 34–84 38–78
Mean age (yr) 49.8 46.7 45.5 54.3 56.4
Male No. of patients 51 17 10 17 7
Age range (yr) 32–81 28–74 14–70 34–81 38–64
Mean age (yr) 45.9 45.1 42.4 52.7 51.1
Female No. of patients 40 24 5 3 8
Age range (yr) 37–84 25–74 41–57 48–84 41–78
Mean age (yr) 49 47.9 51.6 63 61
Phenylalanine
All patients No. of patients 131 60 34 22 15
Age range (yr) 19–86 19–82 20–72 41–82 37–86
Mean age (yr) 50.7 49.9 44.9 55.9 59.3
Male No. of patients 61 17 20 15 9
Age range (yr) 19–82 19–78 20–70 41–80 44–70
Mean age (yr) 49.8 50 40.7 56.5 58.2
Female No. of patients 70 43 14 7 6
Age range (yr) 21–86 21–82 31–72 46–63 37–86
Mean age (yr) 51.5 49.9 50.9 54.6 61
Amino acid 231
Glycine
All patients No. of patients 153 67 34 30 22
Age range (yr) 14–84 19–82 14–70 34–82 37–78
Mean age (yr) 50.3 50.2 42.6 54.6 57
Male No. of patients 83 25 23 24 11
Age range (yr) 14–84 19–78 14–70 34–82 38–68
Mean age (yr) 48.6 49.3 40.7 53 54.5
Female No. of patients 70 42 11 6 11
Age range (yr) 25–84 25–82 31–61 48–84 37–78
Mean age (yr) 52.3 50.7 46.8 60.7 59.5
Otherb
All patients No. of patients 69 34 15 12 8
Age range (yr) 21–86 27–74 31–72 41–81 44–86
Mean age (yr) 50.4 45.5 50.5 57.3 60.3
Male No. of patients 29 9 7 8 5
Age range (yr) 29–81 29–61 31–61 41–81 44–70
Mean age (yr) 50 42.6 43.3 60.1 47.6
Female No. of patients 40 25 8 4 3
Age range (yr) 21–86 21–74 37–72 46–57 48–86
Mean age (yr) 50.7 46.6 56.9 51.8 66.7
Amino acid 196
Serine
All patients No. of patients 148 64 28 31 25
Age range (yr) 19–84 19–82 23–70 34–84 37–78
Mean age (yr) 50.9 48.8 43.6 56.7 57.4
Male No. of patients 76 22 18 24 12
Age range (yr) 19–82 19–76 23–70 34–82 38–68
Mean age (yr) 49.6 46.6 40.7 56.1 55.5
Female No. of patients 72 42 10 7 13
Age range (yr) 21–84 21–82 31–61 48–84 37–78
Mean age (yr) 52.3 48.4 48.7 58.9 59.1
Continued on following page
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did exist between disease state and amino acid 231 but only
within the non-EPIYA-ABD population (P  0.0367). This
again suggests that the effects of different virulence factors or
polymorphisms within these virulence factors may be masked
when the CagA allele is present.
DISCUSSION
Polymorphisms within vacA have been studied for several
years but have primarily focused on the s and m regions.
However, the newest identified polymorphic region of vacA,
the i region, has been suggested to be a determinant of vacu-
olating activity, as well as the best indicator of disease pathol-
ogy, at least in Western strains (2, 16, 47). Within this region,
three clusters of polymorphisms have been reported: cluster A,
B, and C (47). In fact, two different amino acid substitutions
within i1 clusters have been identified as potential markers for
Taiwanese VacA (50). However, as previously suggested by
our group (27) both of these amino acid substitutions are
conserved within the South Korean population: we found a
phenylalanine instead of a tyrosine for the first amino acid in
cluster A (94.4%) and a methionine for the second asparagine
within cluster C (99.5%). This suggests that these amino acid
substitutions are not limited to the Taiwanese population but
could serve as a general marker for East Asian VacA.
Further analysis of the amino acid consensus sequences of
clusters A, B, and C revealed several differences from the
consensus sequence previously reported by Rhead et al. (47)
and Chung et al. (11). This South Korean population provides
the largest number of VacA i sequences analyzed so far, al-
lowing us to better identify amino acids that differ between the
i1 and i2 alleles (Fig. 2). Cluster A was well conserved in
strains, and the i1 and i2 consensus sequences were very similar
to each other. Interestingly, each of the three i3 strains that we
identified showed differences in cluster A; one of the strains
contained the exact i1 consensus sequence, one contained the
exact i2 consensus sequence, and one was different (Fig. 2),
indicating that these strains may be in the process of evolving
from one allele to the other allele.
Within cluster B, the fifth, ninth, and tenth amino acids are
the main differences between the i1 and i2 alleles. The ninth
amino acid (residue 231) was previously shown to have a role
in disease (50). We found this residue was not variable in the
small subset of i2 strains within our population, though it was
variable within the i1 strains. Moreover, this variability at
amino acid 231 does impact disease development but only
within strains containing a non-EPIYA-ABD CagA. This find-
ing suggests that within strains carrying the most virulent CagA
allele, this residue is less important.
The differences between the i1 and i2 alleles were most
pronounced in cluster C. This is primarily due to the addition
of three polar amino acids, asparagine, histidine, and serine,
but there were an additional five amino acids that are different
in the i1 and i2 alleles (Fig. 2). Since both clusters B and C have
been suggested to affect toxin activity, studies examining the
specific roles of these amino acids in vacuolating activity would
TABLE 2—Continued
Amino acid and
patient gender Parameter
Value for parameter for patientsa
All Gastritis Duodenal ulcers Gastric ulcers Gastric cancer
Leucine
All patients No. of patients 74 37 21 11 5
Age range (yr) 14–86 24–78 14–72 38–69 44–86
Mean age (yr) 49.1 48.4 47 50.5 60.4
Male No. of patients 36 12 12 8 4
Age range (yr) 14–78 28–78 14–70 38–69 44–70
Mean age (yr) 48.8 49.2 42.1 49.6 54
Female No. of patients 38 25 9 3 1
Age range (yr) 24–86 24–74 39–72 46–57 86
Mean age (yr) 50.7 48 53.7 53 N/A
a N/A, not applicable.
b Any amino acid other than a glycine at this position.
TABLE 3. P values of the distribution of amino acids at
polymorphic positions in patients with various diseases
Comparison of the distribution of amino
acids in patients with
different diseasesa
P valuea for the distribution of
amino acids at position:
151 231 196
Across all diseases 0.2639 0.8914 0.0624
Gastritis vs all other diseases
(duodenal ulcers, gastric ulcers,
and gastric cancer)
1.0000 0.4694 0.3916
Gastritis vs peptic ulcers (both
duodenal and gastric ulcers)
0.7700 0.6418 0.8808
Gastritis vs duodenal ulcers 0.2818 0.8529 0.4796
Gastritis vs gastric ulcers 0.4627 0.6946 0.2500
Gastritis vs gastric cancer 0.4044 0.5132 0.0460
Duodenal ulcers vs all other diseases 0.1025 1.0000 0.1237
Duodenal ulcers vs gastric ulcers 0.1306 1.0000 0.1250
Duodenal ulcers vs gastric cancer 0.0994 0.8015 0.0254
Gastric ulcers vs all other diseases 0.3847 0.8533 0.3636
Gastric ulcers vs gastric cancer 1.0000 1.0000 0.3994
Gastric cancer vs all other gastric
diseases
0.3207 0.6732 0.0389
Gastric cancer vs peptic ulcers 0.2910 0.8201 0.0689
a Associations that were statistically significant and the corresponding P values
are in boldface type.
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be of interest. Creation and examination of the activity of
isogenic toxin derivatives in which only the residue of interest
was different would aid in this effort. Furthermore, given that
the i3 strains appear to be hybrids of the i1 and i2 alleles at
clusters B and C, it would be of significant interest to deter-
mine whether there is a functional difference between the
vacuolating activity of i1, i2, and i3 toxins. To further investi-
gate the roles of these clusters, toxin activity could be assessed
among the three i3 strains we identified and strains that con-
tain an i1 cluster B and i2 cluster C. Finally, even though it has
not been suggested to be important for activity, it would also be
interesting to assess the sequences from cluster A to analyze
the variance of amino acids four and six, potentially providing
insight into VacA evolution.
Interestingly, five possible different amino acids were found
to occur at amino acid 231 (the ninth amino acid of cluster B):
glycine, serine, arginine, asparagine, and aspartic acid. Of
these five amino acids, glycine is the only nonpolar amino acid,
suggesting that perhaps this residue is important for the con-
formation or folding of VacA. Indeed, this could explain the
statistical association between the distribution of amino acids
at this position with every region of VacA. Previous work
showed that a glycine found at amino acid 231 was linked to
disease development within the Taiwanese population (50).
However, in our South Korean population, the distribution of
amino acids found at this position had no overall impact on
disease development. Conversely, there was a strong associa-
tion with variation at this residue and the cagA allele and two
direct three-way associations between disease state, the distri-
bution of amino acids at this position, and either cagA allele or
amino acid 196, both of which affect the development of cancer
in this population (Table 3) (27, 29). Given the association with
cagA, the impact of this amino acid across East Asian and
Western CagA alleles was examined, and a direct two-way
association between amino acid 231 and disease state was
found among the strains that carry non-EPIYA-ABD CagA
alleles. This emphasizes the importance of the i region when
carried within the context of Western strains and suggests that
there may be other factors that are more important in disease
development or that mask the importance of the i region in the
development of severe disease among East Asian strains. In-
deed, even among Western strains, the CagA allele was the
most important virulence factor for development of gastric
cancer, whereas the VacA i region was the best indicator for
development of peptic ulcer disease (5). Further exploration of
differences between Western and East Asian strains may help
to explain the exact mechanism of interaction of CagA and
VacA.
Variation at amino acid 196 was statistically linked only to
the vacA i region, indicating that it may be a true indicator of
i-region-associated impacts. While overall this amino acid was
not linked to disease state and there was not an association
between the less severe disease states and distribution of
amino acids at position 196, there was a statistical difference in
the distribution of amino acids at this position when gastric
cancer was compared to any other disease state, gastritis, or
duodenal ulcers. However, there was no statistical difference in
the distribution of amino acids at this position between gastric
cancer and gastric ulcers. This may be due to the fact that
gastric ulcers can be a precursor to gastric cancer (19, 36).
Given this, more-severe disease states (gastric cancer and ul-
cers) were next compared to less-severe disease manifestations
(duodenal ulcers and gastritis), and a statistical association was
identified. This suggests that variation at residue 196 is impor-
tant for progression to severe disease and that the overall
significance of the amino acids found at this position is prob-
ably masked by the lack of association between gastric cancer
and gastric ulcers.
While a serine at this position was more prevalent across the
overall population, patients suffering from gastric cancer were
five times more likely to carry a serine at this location. How-
ever, all of the i2 alleles carried a leucine at this position, and
if this trend holds true for a larger population of i2 strains, then
its contribution to disease development may become more
evident. Since the distribution of amino acids at this position
was linked not only to the overall Vac allele but also specifi-
cally to the i region, the different prevalences of serine found
at this position may explain why a previous study concluded
that the i region was the best predictor of disease (47).
Since both CagA and VacA polymorphisms influence dis-
ease development, perhaps it is not surprising that within a
population of isolates from a country with one of the highest
rates of H. pylori colonization and gastric cancer (21, 51, 55),
the majority of strains carry genes that encode the most toxic
form of both CagA and VacA. While polymorphisms impor-
tant for disease severity have been identified within both CagA
and VacA individually, strains that are CagA positive and carry
the VacA s1-m1 allele have been shown to induce highly active
corpus gastritis, which has been associated with the progres-
sion to gastric cancer (37–39). Additionally, we recently pre-
sented evidence that within this high-risk population for gastric
cancer development, there is a significant interaction between
the VacA allele, CagA allele, and disease state (27). However,
the reason only a small percentage of the population develops
cancer is still unclear. Although it is evident that host, envi-
ronmental, and bacterial factors play a role in H. pylori-induced
disease (reviewed in references 8 and 57), additional studies
are required to determine the contribution of all of these
factors, both individually and in conjunction with each other, to
the development of H. pylori-induced gastric cancer.
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